Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 273

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium

Open access
Blankenberg, Stefan, Salomaa, Veikko, Makarova, Nataliya, Ojeda, Francisco, Wild, Philipp, Lackner, Karl J., Jørgensen, Torben, Thorand, Barbara, Peters, Annette, Nauck, Matthias, Petersmann, Astrid, Vartiainen, Erkki, Veronesi, Giovanni, Brambilla, Paolo, Costanzo, Simona, Iacoviello, Licia, Linden, Gerard, Yarnell, John, Patterson, Christopher C., Everett, Brendan M., Ridker, Paul M., Kontto, Jukka, Schnabel, Renate B., Koenig, Wolfgang, Kee, Frank, Zeller, Tanja, Kuulasmaa, Kari·2016·European Heart Journal

Abstract

AIMS: Our aims were to evaluate the distribution of troponin I concentrations in population cohorts across Europe, to characterize the association with cardiovascular outcomes, to determine the predictive value beyond the variables used in the ESC SCORE, to test a potentially clinically relevant cut-off value, and to evaluate the improved eligibility for statin therapy based on elevated troponin I concentrations retrospectively. METHODS AND RESULTS: Based on the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) project, we analysed individual level data from 10 prospective population-based studies including 74 738 participants. We investigated the value of adding troponin I levels to conventional risk factors for prediction of cardiovascular disease by calculating measures of discrimination (C-index) and net reclassification improvement (NRI). We further tested the clinical implication of statin therapy based on troponin concentration in 12 956 individuals free of cardiovascular disease in the JUPITER study. Troponin I remained an independent predictor with a hazard ratio of 1.37 for cardiovascular mortality, 1.23 for cardiovascular disease, and 1.24 for total mortality. The addition of troponin I information to a prognostic model for cardiovascular death constructed of ESC SCORE variables increased the C-index discrimination measure by 0.007 and yielded an NRI of 0.048, whereas the addition to prognostic models for cardiovascular disease and total mortality led to lesser C-index discrimination and NRI increment. In individuals above 6 ng/L of troponin I, a concentration near the upper quintile in BiomarCaRE (5.9 ng/L) and JUPITER (5.8 ng/L), rosuvastatin therapy resulted in higher absolute risk reduction compared with individuals <6 ng/L of troponin I, whereas the relative risk reduction was similar. CONCLUSION: In individuals free of cardiovascular disease, the addition of troponin I to variables of established risk score improves prediction of cardiovascular death and cardiovascular disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehw172

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Cited by

See all 273

Metadata

Authors
Blankenberg, S., Salomaa, V., Makarova, N., Ojeda, F., Wild, P., Lackner, K. J., Jørgensen, T., Thorand, B., Peters, A., Nauck, M., Petersmann, A., Vartiainen, E., Veronesi, G., Brambilla, P., Costanzo, S., Iacoviello, L., Linden, G., Yarnell, J., Patterson, C. C., Everett, B. M., Ridker, P. M., Kontto, J., Schnabel, R. B., Koenig, W., Kee, F., Zeller, T., & Kuulasmaa, K.
Venue
European Heart Journal
Published
2016-05-12
Volume
37
Issue
30
Pages
2428-2437
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2377353977
Cited by
273
References
51
FWCI
29.21
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium. https://app.cochat.ai/papers/10.1093/eurheartj/ehw172
The paper
Blankenberg, S., Salomaa, V., Makarova, N., Ojeda, F., Wild, P., Lackner, K. J., Jørgensen, T., Thorand, B., Peters, A., Nauck, M., Petersmann, A., Vartiainen, E., Veronesi, G., Brambilla, P., Costanzo, S., Iacoviello, L., Linden, G., Yarnell, J., Patterson, C. C., . . . Kuulasmaa, K. (2016). Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium. European Heart Journal. https://doi.org/10.1093/eurheartj/ehw172

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.